9 /100
LOW RISK
Score updated Jul 13, 2026

MET-PA — MetLife, Inc. Dilution Risk Tracker

Track MET-PA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MET-PA — Get alerts when the score changes →

As of July 13, 2026, MetLife, Inc. (MET-PA) has a DilutionWatch DilutionScore of 9/100, rated LOW dilution risk. MetLife, Inc. has 643.44M shares outstanding, 1389 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
17
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for MET-PA.
🔔 Track MET-PA — Get forecast alerts →

💹 Market Data

Market CapN/A
Shares Outstanding643.44M
Float537.55M
Cash$27.64B
Debt$19.28B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 23.1% shares (2026Q1 vs prior)
1389 institutional holders · 637.19M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 71.71M shares
#2 BlackRock, Inc. 51.42M shares
#3 Dodge & Cox 51.11M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short interest data updating...

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for MET-PA Shareholders

MetLife, Inc. (MET-PA) has a DilutionScore of 9/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for MET-PA shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for MET-PA in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for MET-PA alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track MET-PA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MET-PA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for MET-PA
📊 MET-PA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MET-PA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.